Novavax Inc
NVAX
NASDAQ
Biotechnology
$8.05
USD
-0.09 (-1.11%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.31B
Volume 2.3M
Price Target
$19.00 – $19.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $19.00 and a min estimate of $19.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$19.00
+$6.5 vs prior
Implied Upside
+136.0%
+80.7% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Thomas Shrader | BTIG | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
PURR
Hyperliquid Strategies Inc
$6.68
▼ -2.0%
ORIC
Oric Pharmaceuticals Inc
$13.87
▲ +1.1%
INBX
Inhibrx Biosciences Inc
$88.37
▼ -8.9%
CGEM
Cullinan Therapeutics Inc
$20.34
▲ +3.6%
AKTS
Aktis Oncology Inc
$24.93
▲ +4.8%
MGTX
MeiraGTx Holdings PLC
$13.52
▲ +6.7%
REPL
Replimune Group Inc
$14.97
▼ -1.4%
CRVS
Corvus Pharmaceuticals Inc
$14.89
▼ -1.6%
GLUE
Monte Rosa Therapeutics Inc
$15.50
▼ -2.1%